Cholesterol Drug Prevents Heart Attacks 鈥 But It Doesn’t Come Cheap
A cholesterol-lowering drug called Repatha cuts the risk of heart attacks, strokes and heart-related death by 20 percent, according to a new study.
Health Industry
2,601 - 2,620 of 3,970 Results
-
-
$89,000 Orphan Drug Gets A New Owner 鈥 And Likely A New Price
Marathon, maker of an expensive treatment for Duchenne muscular dystrophy, sells the drug for $140 million in cash and stock to PTC Therapeutics.
-
Treating Cancer: Hope Vs. Hype
Sticker Shock Forces Thousands Of Cancer Patients To Skip Drugs, Skimp On Treatment
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
By Liz Szabo -
Repeal & Replace Watch
By The Numbers: Trump’s Choice For FDA Chief Is Versatile, Entrenched In Pharma
The numbers show that President Trump鈥檚 choice for FDA commissioner, Scott Gottlieb, has long-standing ties to pharmaceutical companies as a board member or consultant and that he had to recuse himself multiple times while working at the FDA.
-
Two Words Can Soothe Patients Who Have Been Harmed: We鈥檙e Sorry
For patients killed or maimed by medical errors, doctors and hospitals still often deny wrongdoing. But newer programs offering prompt disclosure of medical errors, an apology and compensation for them or their families are growing.
-
Repeal & Replace Watch
Say What? Fact-Checking The Chatter Around The GOP Health Bill
In the heated political arguments as Republicans rush to repeal and replace the Affordable Care Act, some facts can get buried.
By Julie Rovner -
By Law, Hospitals Now Must Tell Medicare Patients When Care Is ‘Observation’ Only
Not being officially admitted 鈥 a status known as observation care 鈥 can have financial consequences for beneficiaries, and patients had often complained they were not informed.
By Susan Jaffe -
HMO Doctors Take Pains To Slash Opioid Prescriptions
A Kaiser Permanente pain management program in Southern California aims to help patients taper off addictive painkillers. Some doctors and patients see it as a godsend; others complain that patients have been cut off medications they need.
By Sam Quinones -
To Save On Drug Costs, Insurer Wants To Steer You To ‘Preferred’ Pharmacies
Blue Shield of California is hoping to steer consumers to "preferred" pharmacies where drugs are cheaper and copays lower.
-
Los Angeles County Scores An E-Success In Managing Specialist Care
An electronic consulting and referral system adopted by the county鈥檚 safety net public health system in 2012 has reduced waiting times for appointments with specialists and eliminated the need for such appointments in a significant number of cases, according to a new study in the journal Health Affairs.
By Anna Gorman -
Three Key Senators Ask GAO To Investigate Possible Abuses Of The Orphan Drug Act
Amid an uproar over high drug prices, three GOP senators are asking the Government Accountability Office to investigate whether the Orphan Drug Act is being abused.
By Sarah Jane Tribble and Sydney Lupkin -
Are Virtual Doctor Visits Really Cost-Effective? Not So Much, Study Says
Rand Corp. finds that telehealth encourages patients to seek care for minor illnesses they wouldn鈥檛 bother to make an office visit for, raising overall health costs.
-
Repeal & Replace Watch
GOP Overhaul Would Keep Obamacare’s ‘Cadillac Tax,’ But Delay It Until 2025
Although Republicans flirted with the idea of changing the tax code so that the value of employer-sponsored health insurance is added to workers鈥 tax liability, House leaders decided to instead keep the ACA鈥檚 tax on insurers and employers that provide generous coverage.
-
California Medical Board President Faces Questions Over Vote In Sexual Misconduct Case
After the medical board reinstated the license of doctor who molested patients, one member 鈥搉ow president -- secured a $40 million donation for a pet project from the doctor鈥檚 relative. He says the two events are unrelated. Critics are demanding an investigation.
By Jenny Gold -
Making Multiple Drugs In One Factory Risks Scary Side Effect Of Shortages
Hundreds of drug brands are being made in giant contract facilities. When a plant shuts down, a widespread drain on supply can result.
-
Patient Advocacy Groups Rake In Donations From Pharma
A new study shows that 83 percent of the largest patient advocacy groups take contributions from drug, medical device or biotech firms.
By Emily Kopp -
Repeal & Replace Watch
Health Insurance: What If You Could Take It With You?
鈥淧ortability鈥 will likely be a buzz word in the health law repeal-and-replace debate, but the concept raises a number of complicated policy issues.
-
President Trump And I Take The Same Drugs 鈥 Except One
An aging writer discovers there are worse things than going bald after examining the side effects of a popular hair loss drug purportedly used by President Donald Trump.
-
For Some Hospice Patients, A 911 Call Saves A Trip To The ER
Hospice groups are teaming up with specially trained paramedics to deal with common problems that worried patients or families incorrectly think need hospital care.
-
Insuring Your Health
Advocates Of Flat-Fee Primary Care See Opening In GOP鈥檚 Market-Driven Approach
In direct primary care, a monthly fee covers routine care, limiting insurers' role. But does it really provide better value?